Skip to main content
European Commission logo print header



Okres sprawozdawczy: 2019-11-01 do 2020-02-29

The HEALTH-IN-A-CONT Feasibility Study (FS) places itself in the middle of the development process which goes from the conceptual idea of our innovation to the commercialization of our solution and its market uptake.
Currently, HEALTH-IN-A-CONT is a functional prototype demonstrated in relevant environment (TRL6). Through the current FS we have carried out an in-depth analysis of the HEALTH-IN-A-CONT project from a technological, commercial and financial point of view, with the objective of selecting the most adequate and appropriate alternatives for its technical development and its profitable market uptake.
The main objectives of the FS are:
* analyzing the Technical Feasibility of our innovation through an in-depth technical analysis of the needed improvements to upgrade the prototype design, solve the issues encountered and assure its optimal technological performance. Studying the integration of specific features to provide additional services. Drafting a first protocol for the standardization of the production process, refining the value chain to increase the production capacity and reduce delivery time).
* studying the Commercial Feasibility through the quantification of the potential markets, competitors, customers, end-users and partners in selected target areas for a successful commercialization. Establishing a comprehensive IPR strategy and management plan (Freedom-to-Operate analysis); analyzing the legal and regulatory requirements in target countries (including the CE marking process); outlining the Dissemination Strategy to exploit project results.
* analyzing the Financial Feasibility of the project, with a 5-year cost and revenue forecast. Refining the company’s Business Model and pricing strategy (including post sale maintenance) for market deployment. Consolidating our Business Plan, including the exploitation strategy based on the FS results.

We have developed an exhaustive risk analysis, including technical, commercial and financial risks to identify major events that could hamper or slow down the EIC Accelerator project development and its successful implementation, and designed possible mitigation measures.

Based on the conclusions of the FS the main activities to be implemented through the EIC Accelerator project have been identified and outlined through a Work Plan.
The main conclusion reached through the FS is that the project to further develop HEALTH-IN-A-CONT to reach commercialization stage should continue as there is clearly a high market demand for the product and little signs of mature market competition up to the present day. Furthermore, the strategic business plan has been reinforced through the positive response from potential customers and relevant stakeholders (regional and national health services, NGOs, governments) and interest to participate in the envisaged HEALTH-IN-CONT EIC Accelerator project.
TECHNICAL FEASIBILITY: we have studied and identified the main technical developments we need to focus on to adjust our prototype design and get to an optimized version ready for piloting and mass production. Our priorities are: i) increasing the container’s external resistance to limit the impact of a potential deflagration on internal medical equipment; ii) controlling and reducing vibrations within the container to make it adapt to include ophthalmology and other precision techniques; iii) modifying and synchronizing the existing ventilation system. We have identified the different containers we are willing to bring onto market (Operating Room; PCR Laboratory for Testing and Analysis; Intensive Care Unit (ICU); Image Diagnosis Laboratory; Service Container), and also additional solutions we will be able to develop on the basis of our 3D models along with the analysis of the customers’ preferences. We have drafted a first protocol for the standardization of the production process. Taking into account our company’s ongoing negotiations with public health institutions in Spain and international NGOs operating in rural and remote areas, we have decided to select them as first pilot partners. (WP3). Finally, we have analyzed our upstream supply chain to help us create a redundancy system and reduce uncertainty.
COMMERCIAL FEASIBILITY: After analyzing the market in the field of emergency and temporary medical services, and the competitor environment, we have concluded that our ability to deliver different container configurations (Set-ups) will enable us to offer a set of fast development mobile hospitals and responses to any pandemic risk area and that can be moved trough large rural areas with lack of necessary facilities. We have also conducted an in-depth analysis of stakeholders which will be key for HEALTH-IN-A-CONT manufacturing, optimization, promotion and market uptake, and in the implementation of the EIC Accelerator project. We have identified and analyzed the first customer groups which can be directly interested in acquiring our solution. The outlined go-to-market strategy targets initial direct opportunities built up from our existing network, building upon the relations we have built with several organizations and institutions providing health services in emergency situations and remote areas. We have designed a Dissemination Strategy to enhance our company’s visibility and its leadership in the mobile field hospital industry. We have conducted a prior patent search, and have not found any existing product limiting our company’s Freedom-to-Operate. We have clearly identified the relevant regulations and international standards to be followed in the design and manufacturing process. We have outlined our business model, composed of 3 business lines: 1) developing and delivering “on demand” containers (set of containers); 2) developing OEM containers to be set up by the customers themselves. 3) R&D Engineering by licensing our innovation to bigger players which will sell our solution and provide maintenance services, and develop additional new variations.
FINANCIAL FEASIBILITY: we have conducted a sale and revenue forecast in a 5 years´ scenario beyond the project. Our company’s ambition is to reach breakeven in year 2 of commercialization. Five years after entering the market (commercialization expected to start in Q3 2022), we forecast to reach a cumulative profit of more than € 77 M by selling more than 600 containers (including revenues from the maintenance service).
Our company’s added value consists in the capability of designing a mobile field hospital solution able to integrate different medical equipment and alternative health care services to meet a variety of customer needs. HEALTH-IN-A-CONT has the advantage of being integrated into a 40ft HQ container and being transportable in its original format without the need for additional assembly work in situ (easy deployment in a few hours). Only our solution can be operated autonomously (Plug&Play with the Service Container for power supply) with no need for external installations and without external modules and couplings. Thanks to the surgical floor and the hydraulic damping system, our solution can be easily transported (wheel, rail, sea) resisting to vibrations, avoiding electronic failures and preserving medical equipment from damaging. We can easily reach large rural and remote areas where the construction of a hospital is not feasible, or employ our solution in emergency situations (natural disasters, pandemic).